Latest News
Feature
Gender wage gap varies by specialty
Average earnings for women and men in 2018 were closest for hematology.
Literature Review
Can intraputamenal infusions of GDNF treat Parkinson’s disease?
The investigational therapy, delivered through a skull-mounted port, was well tolerated in a randomized, controlled trial and open-label extension...
Latest News
MIPS: Nearly 20% of small/solo practices took a pay cut in first year
Overall, 93% of participants got some kind of pay bump for 2017.
Feature
ABIM contests class-action lawsuit, asks judge to dismiss
The plaintiffs are asking a judge to find ABIM in violation of federal antitrust law and to bar the board from continuing its MOC process.
From the Journals
Surge of gabapentinoids for pain lacks supporting evidence
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
Conference Coverage
Expert calls for more ‘ethnocentric’ research in MS
DALLAS – Understanding the effect of race/ethnicity is crucial to understanding MS disparities.
Conference Coverage
Smartphone technology helps to detect, track eye changes in MS
DALLAS – The testing is low-cost, large-scale, and enables clinicians to study genotype-phenotype comparisons.
Conference Coverage
Study eyes serious adverse events from long-term rituximab use in MS
DALLAS – No patient experienced an infusion reaction requiring hospitalization.
Conference Coverage
Patient selection for acute stroke thrombectomy stirs controversy
News from the FDA/CDC
FDA approves solriamfetol for daytime sleepiness treatment
Solriamfetol is the first dopamine and norepinephrine reuptake inhibitor approved to treat narcolepsy and obstructive sleep apnea.
From the Journals
Rituximab boosts survival in primary CNS lymphoma
The triplet combination of rituximab plus combination high-dose methotrexate and temozolomide could be a safe and effective first-line option for...